Neutral impactCorporate Action

Curis Lifesciences Limited — Appointment

NSE 13 Jul·13 Jul 2026, 1:53 pm
Curis Lifesciences

Curis Lifesciences Limited has informed the Exchange regarding Appointment of Mr Devabhai Hamirbhai Jadeja as Non- Executive Independent Director of the company w.e.f. July 13, 2026.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Curis Lifesciences (CURIS).
  • Category: Corporate Action.

Why it matters

A routine update for Curis Lifesciences. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.